Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

27.93
Delayed Data
As of May 24
 +0.43 / +1.56%
Today’s Change
25.98
Today|||52-Week Range
43.85
-13.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues213.4M219.7M233.4M243.2M
 
 
 
 
 
Cost of Goods Sold88.6M91.7M101.8M154.0M
 
 
 
 
 
Depreciation And Amortization22.3M22.7M22.7M--
 
 
 
 
 
Operating ExpensesGross Income102.5M105.3M108.9M89.2M
 
 
 
 
 
General Expenses84.1M79.5M86.2M94.8M
 
 
 
 
 
Research And Development11.3M11.6M10.9M11.7M
 
 
 
 
 
Total Operating Expenses195.0M193.9M210.8M248.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income18.4M25.8M22.6M-5.6M
 
 
 
 
 
Extraordinary Credit637.0K160.0K5.1M0.00
 
 
 
 
Extraordinary Charge-14.8M-6.7M-88.7M--
 
 
 
 
Interest Expense On Debt2.6M2.8M2.4M2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.6M16.6M-63.3M-8.3M
 
 
 
 
 
Income Taxes-1.9M-3.7M-3.9M-467.0K
 
 
 
 
 
Net Income-267.0K12.9M-59.4M-8.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.4M50.7M50.7M50.9M
 
 
 
 
 
Shares To Calculate EPS Diluted51.4M51.2M50.7M50.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01$0.25-$1.17-$0.17
 
 
 
 
 
EPS Diluted-$0.01$0.25-$1.17-$0.17